Fierce Biotech January 24, 2023
Helen Floersh

While it remains to be seen how delivery, manufacturing and pricing will play out, Jennifer Doudna, Ph.D., and co-author Joy Wang predict that the next 10 years will see CRISPR technology become faster and cheaper to use for applications like genome sequencing. (LuckyStep48/iStock/Getty Images Plus)

It took five years to sequence the first human genome. Today, it takes less than 24 hours.

Rapid genome sequencing is one of the many advances indebted to CRISPR-Cas9, the powerful gene editing technology that has fundamentally changed research and biomedicine in the 10 years since its advent. In a new review published Jan. 20 in Science by CRISPR pioneer Jennifer Doudna, Ph.D., and Doudna lab doctoral candidate Joy Wang, the researchers lay...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Precision Medicine
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs

Share This Article